Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
He holds a Master’s in Management from the National University of Singapore
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
India has taken the lead in recognising NAFLD as a major non-communicable disease
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Subscribe To Our Newsletter & Stay Updated
